Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 févr. 2026 02h10 HE | Source: Michigan Integrative Health

Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients

DETROIT, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...
02 févr. 2026 14h33 HE | Source: Michigan Integrative Health

Michigan Integrative Health Expands Stem Cell Therapy Services to Welcome Canadian Patients

Detroit, MI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Michigan Integrative Health Stem Cells, a leading provider of stem cell therapy and regenerative medicine in Shelby Township, Michigan, announces the...
02 févr. 2026 07h00 HE | Source: Repairon GmbH

Groundbreaking therapy for advanced heart failure

GÖTTINGEN, Germany, Feb. 02, 2026 (GLOBE NEWSWIRE) -- German biotech company Repairon GmbH announced the formation of its fully owned subsidiary, Repairon USA, Inc., to enable the expansion of...
30 janv. 2026 16h03 HE | Source: NurExone Biologic Inc

NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise

TORONTO and HAIFA, Israel, Jan. 30, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced changes to its board of...
30 janv. 2026 08h00 HE | Source: California Institute for Regenerative Medicine (CIRM)

CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases

South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases,...
29 janv. 2026 10h26 HE | Source: Research and Markets

Precision Medicine in Oncology Collaboration and Licensing Agreements Trends Report 2025 with Directory of 879 Deals - Upfront, Milestone, Royalties Terms, Company A-Z, Deal Type and Therapy Area

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...
29 janv. 2026 10h23 HE | Source: Research and Markets

Cell Therapy Collaboration and Licensing Agreements Trends Report 2025 with Directory of 989 Deals - Upfront, Milestone, Royalties, Company A-Z, Deal Type and Therapy Area

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Cell Therapy Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering. This report contains a...
26 janv. 2026 05h34 HE | Source: Research and Markets

Adeno Associated Virus Vector Manufacturing Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Adeno Associated Virus Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
23 janv. 2026 07h59 HE | Source: Research and Markets

Global Cell and Gene Therapy Manufacturing QC Market Forecast to Achieve USD 2.01 Billion by 2031: Automation and Digitalization Revolutionizing the Landscape

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Manufacturing QC Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
23 janv. 2026 07h58 HE | Source: Research and Markets

Cell Therapy Human Raw Materials Market Set to Surge with 12.43% CAGR, Driven by Oncological Advancements and Regenerative Medicine Investments

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cell Therapy Human Raw Materials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...

Page suivante